Use of Buckysome or Carbon Nanotube for Drug Delivery
6 Assignments
0 Petitions
Accused Products
Abstract
Compositions and methods for administering a therapeutic agent to a mammal are disclosed. The compositions comprise either (i) vesicles comprising an amphiphilic substituted fullerene, wherein the therapeutic agent is present in the vesicle interior or between layers of the vesicle wall, (ii) a substituted fullerene, comprising a fullerene core and a functional moiety, wherein the therapeutic agent is associated with the substituted fullerene, or (iii) carbon nanotubes, wherein the therapeutic agent is covalently bonded to the carbon nanotubes.
-
Citations
33 Claims
-
1-16. -16. (canceled)
-
17. A derivatized carbon nanotube, comprising:
-
a carbon nanotube, and at least one therapeutic agent covalently attached to the carbon nanotube. - View Dependent Claims (18, 19, 20)
-
-
21. A method of delivering a therapeutic agent to a mammal, comprising
(i) administering to the mammal a derivatized carbon nanotube, comprising a carbon nanotube and at least one therapeutic agent covalently attached to the carbon nanotube.
Specification